American Journal of Cardiology
Volume 105, Issue 8 , Pages 1090-1094 , 15 April 2010

Importance of Measuring Glycosylated Hemoglobin in Patients With Myocardial Infarction and Known Diabetes Mellitus

  • Joshua M. Stolker, MD

      Affiliations

    • St. Luke's Mid America Heart Institute, Kansas City, Missouri
    • University of Missouri–Kansas City, Kansas City, Missouri
    • Corresponding Author InformationCorresponding author: Tel: 816-932-5475; fax: 816-932-5613
    • ,
  • Dazhong Sun, MD

      Affiliations

    • St. Luke's Mid America Heart Institute, Kansas City, Missouri
    • University of Missouri–Kansas City, Kansas City, Missouri
    • ,
  • Darcy G. Conaway, MD

      Affiliations

    • University of Missouri–Kansas City, Kansas City, Missouri
    • ,
  • Philip G. Jones, MS

      Affiliations

    • St. Luke's Mid America Heart Institute, Kansas City, Missouri
    • ,
  • Frederick A. Masoudi, MD, MSPH

      Affiliations

    • University of Colorado, Aurora, Colorado
    • Denver Health Medical Center, Denver, Colorado
    • ,
  • Pamela N. Peterson, MD, MSPH

      Affiliations

    • University of Colorado, Aurora, Colorado
    • ,
  • Harlan M. Krumholz, MD, SM

      Affiliations

    • Yale University, New Haven, Connecticut
    • ,
  • Mikhail Kosiborod, MD

      Affiliations

    • St. Luke's Mid America Heart Institute, Kansas City, Missouri
    • University of Missouri–Kansas City, Kansas City, Missouri
    • ,
  • John A. Spertus, MD, MPH

      Affiliations

    • St. Luke's Mid America Heart Institute, Kansas City, Missouri
    • University of Missouri–Kansas City, Kansas City, Missouri

Received 1 August 2009 ,Revised 1 December 2009 ,Accepted 1 December 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by Grant P50 HL077113 from the National Heart, Lung, and Blood Institute Specialized Center for Clinically Oriented Research in Cardiac Dysfunction and Disease, Bethesda, Maryland. The Prospective Registry Evaluating Myocardial Infarction Patients: Events and Recovery–Quality Improvement (PREMIER-QI) was sponsored primarily by CV Therapeutics (Palo Alto, California), which had no role in study design, data analysis or interpretation, or drafting and approving this report.

PII: S0002-9149(09)02838-0

doi: 10.1016/j.amjcard.2009.12.010

American Journal of Cardiology
Volume 105, Issue 8 , Pages 1090-1094 , 15 April 2010

Article Tools

* Image Usage & Resolution